* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Download Physiological Variations of FDG Distribution and Pitfalls of
Industrial radiography wikipedia , lookup
Radiation burn wikipedia , lookup
Medical imaging wikipedia , lookup
Center for Radiological Research wikipedia , lookup
Neutron capture therapy of cancer wikipedia , lookup
Nuclear medicine wikipedia , lookup
Radiosurgery wikipedia , lookup
Radiation therapy wikipedia , lookup
Proton therapy wikipedia , lookup
Physiological Variations of FDG Distribution and Pitfalls of Interpretation of PET-CT Dominique Delbeke, MD, PhD Vanderbilt University Medical Center Nashville, Tennessee VUMC PET conference August 2009 Outline FDG distribution Neck: glandular, lymphoid, muscular Muscular system GI GU GYN Therapy-related changes Inflammatory processes PET technical artifacts PET/CT technical artifacts SNM PET/CT guidelines Preparation of the patient Reporting Normal Distribution of FDG Brain: high uptake in the gray matter Myocardium: variable uptake Lungs: low uptake Mediastinum: low uptake Liver: low uptake GI tract: variable activity (esophagus, stomach, colon) Urinary tract: excretes FDG Muscular system: low uptake at rest Cook GJR, et al: Semin Nucl Med 1996;26:308-314 Physiological Variations of FDG Distribution Neck: Glandular tissue Lymphoid tissue Muscles Brown fat Laryngeal muscles: vocalis and crico-arytenoid Parotid glands Oculomotor muscles Oculomotor muscles nasopharynx Parotid glands Tonsils Sublingual gland and myelohyoid muscles Submandibular glands Laryngeal muscles Patient with lymphoma in remission 6 months earlier Uptake in masseter muscles due to chewing Initial staging lung cancer Uptake in R masseter and pterygoid 67 year-old female with medullary thyroid ca and rising calcitonin Left vocal cord paralysis 16 year old female with lymphoma s/p therapy Brown fat Physiological Variations of FDG Distribution FDG uptake in both the thyroid gland and laryngeal muscles Hashimoto Thyroiditis From: Delbeke D et al (eds): “Practical FDG Imaging: A teaching File” Springer-Verlag 2002. Physiological Variations of FDG Distribution Muscular system: Under tension or after exercise (e.g. chewing, talking, swallowing, eye movement, hyperventilating, walking..) Insulin endogenous or exogenous Exercise Endogenous insulin 51 year-old male with relapse Hodgkin’s lymphoma S/P chemotherapy 36 year-old man s/p lung transplant for hypersensitivity pneumonitis, now lung nodules other patient with lung cancer Respiratory insufficiency 28 year-old male with Hodgkin’s lymphoma and suspected recurrence Nausea and vomiting Weight lifting 22 year-old female with DLBCL s/p completion of therapy Honeymoon effect Physiological Variations of FDG Distribution: GI GI tract: Lymphoid tissue Smooth muscle activity Stools Metformin Inflammatory disease… Crohn’s disease Lung cancer and colitis From: Delbeke D et al (eds): “Practical FDG Imaging: A teaching File” Springer-Verlag 2002. 67 year-old female presents for initial staging of laryngeal cancer Metformin Gontier E et al. Eur J Nucl Med Mol Imaging 2008;35(1):95-99 Physiological Variations of FDG Distribution: GI 45-year-old man who completed chemo and radiation therapy for SCC of the larynx presents with dysphagia Esophagitis 65year-old female with NSCLC referred for initial staging 1) RUL NSCLC 2) Hepatic metastases 3) Hiatal hernia From: Delbeke D et al (eds): “Practical FDG Imaging: A teaching File” Springer-Verlag 2002. Physiological Variations of FDG Distribution: GU Patient evaluated for suspected recurrent colorectal cancer Right pelvic kidney Renal transplant 55-year-old male s/p resection abdominal sarcoma 8 months ago, presenting with suspicion of recurrence on CT abdominal recurrent sarcoma and horseshoe kidney Physiological Variation of FDG Distribution: GU/GYN 36 year old female with a 1 cm SPN Horseshoe kidney and fibroids Physiological Variation of FDG Distribution: GYN 33 year-old female just diagnosed with breast cancer Uterus in a menstruating female 17 year-old female with HD in the neck and chest s/p completion of therapy Ovaries benign Lerman H et al. J Nucl Med 2004;45:266-271. Physiological Variations of FDG Distribution: GYN Dense breast Lactating breasts Vranjesevic D wet al. J Nucl Med 2003;44(8):1238-1242 Monitoring Response to Therapy with FDG PET: Timing in Relation to Surgical Therapy Surgery: ~ 2 months for surgical site Anytime for staging elsewhere. 58 year old man s/p mediastinoscopy 1 week earlier demonstrating NSCLC 62 year-old male s/p resection of recurrent lymphoma of the small bowel 2 weeks earlier. Diagnosis: postoperative changes 45 year-old female with anaplastic lymphoma S/P therapy evaluated for bone marrow transplant July 05 Bone marrow biopsy L iliac crest Monitoring Response to Therapy with FDG PET: Timing in Relation to Radiation Therapy More than 6 months after completion of radiation: FDG uptake indicates tumor recurrence Early after radiation (within 2 months…up to…..): FDG uptake matching the radiation port due to inflammatory changes Recommendations: Wait as long as possible after radiation before performing FDG PET Comparison to baseline PET is helpful Knowledge of radiation ports is helpful. 48 year-old man with HD diagnosed in 2003 48 year old man with lymphoma diagnosed 1 year earlier and treated with XRT to left axilla. He recurred 2 months earlier and was treated with chemotherapy. 57 year old male diagnosed with esophageal cancer in July and treated with chemoradiation completed two weeks before his follow-up PET scan July 29 Oct 19 61 year-old female with T-cell lymphoma of left breast and mediastinum s/p chemo and radiation Radiation esophagitis 33 year-old male with DLBCL s/p chemo and radiation therapy to mediastinum 2 year earlier and referred for restaging Radiation pneumonitis 81-year-old male with large cell carcinoma treated with radiation therapy Radiation pneumonitis From: Delbeke D et al (eds): “Practical FDG Imaging: A teaching File” Springer-Verlag 2002. Monitoring Response to Therapy with FDG PET: Timing in Relation to Chemotherapy Physiological uptake in response to therapy For 2-4 weeks: Bone marrow and spleen due to regenerating bone marrow (hyperplasia) Worse if bone marrow stimulating factors have been administered with chemotherapy (e.g. G-CSF, neupogen) Possible transient cellular stunning Possible inflammatory response: metabolic flare Recommendation: At least 2 weeks after last chemotherapy or just before next cycle 2-months after completion of therapy 1 day post G-CSF A 42-year-old female who underwent a left mastectomy for breast carcinoma followed by chemotherapy presented with rising tumor 2 weeks later markers Diagnosis: Severe bone marrow uptake related to administration of G-CSF the day before Thymic hyperplasia Benign Diseases that Can Mimick Malignancy Granulomatous lesions: e.g. tuberculosis, fungi, sarcoidosis…. Other inflammatory processes Hyperplasia/dysplasia 42-year-old male after completion of therapy for SCC of the oropharynx Sarcoidosis From: Delbeke D et al (eds): “Practical FDG Imaging: A teaching File” Springer-Verlag 2002. 55 year old female with recurrent melanoma 1) Recurrent melanoma in left axilla 2) Vaccine injection in right axilla and bilateral groins 76 year-old male with pulmonary nodule Pericarditis 76 year-old male with pulmonary nodule Recent laminectomy 72-year-old female with weight loss, fatigue, fevers and chills and a lesion in the caudate lobe of the liver on CT Diagnosis: Surgery: Acute gangrenous and hemorrhagic cholecystitis with abscess formation extending in the right colon Suspicion of Klatskin Acute pancreatitis 43 year old s/p thyroidectomy for papillary thyroid cancer presenting with borderline elevation of Tg, has Tg Ab and a negative I-131 scan at time of previous recurrence. Bx: granulomatous disease Nocardia abscess A 80 year-old male with a history of amyloidosis presented for evaluation of SPN Amyloidosis 64-year-old male with recurrent left neck lymphoma post-stem cell transplant From Vitola JV and Delbeke D. Nuclear Cardiology & Correlative Imaging, Springer-Verlag, 2004 60 year old male with NSCLC 2 years earlier presenting with SVC syndrome Thrombus in SVC 68-year-old male with mantle cell lymphoma with multiple LN in the neck and abdomen Diagnosis: 1) False – low grade lymphoma 2) Fem-Fem graft PET Technical Artifacts Malfunctioning detector Injection site Indwelling catheter Sentinel lymph node visualization 57-year-old male with a history of lung cancer believed to be in remission and referred for follow-up Diagnosis: Malfunctioning detector 34-year-old female presents with persistent lympadenopathy in the porta hepatis after completion of therapy for lymphoma Diagnosis: FDG injection in port and visualization of indwelling catheter From: Delbeke D et al (eds): “Practical FDG Imaging: A teaching File” Springer-Verlag 2002. A 65-year-old male with a history of prostate cancer was referred for evaluation of a pulmonary nodule. Arterial injection 60 year old male with multiple relapse of lymphoma, now new 1 cm mediastinal LN Dose infiltration and FDG uptake in sentinel LN Artifacts on CT-attenuated PET images Inaccurate co-registration due to: Random motion less likely with short transmission scan Artifacts on CT-attenuated PET images Inaccurate co-registration due to: Respiratory motion Inaccurate localization of lesion in the region of diaphragm (dome of liver versus lung bases) in 2% of patients Curvilinear cold artifacts along diaphragm 65 year-old with lung cancer s/p XRT to mediastinum 1 week earlier Radiation esophagitis Goerres GW et al. Radiology 2003;226:906-910. Osman MM et al. Eur J Nucl Med 2003;30:603-606. Osman MM et al. J Nucl Med 2003;44:240-243. Artifacts on CT-attenuated PET images Hot spots due to over-correction related to: IV contrast Focal accumulation of oral contrast Metallic implants (dental, hardware…) Overestimation of SUV values by up to 10% compared to Ge68 based attenuation correction. Antoch G et al.J Nucl Med 2002;43:1339-1342. No correction Cohade C et al. J Nucl Med 2003;44:412-416. Goerres GW et al. Eur J Nucl Med Molec Imag 2002;29:367-370. Nakamoto Y et al. J Nucl Med 2002;43:1137-1143. Antoch G et al. J Nucl Med 2004: 45 (Suppl): 56S. standard Thank you! Brazil 2004